ArticleLasers in medical science2026
A numerical study on the effect of laser therapy against port-wine stain by administering artificial red blood cells.
Article in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative evaluation of long-pulsed Nd: YAG and pulsed dye lasers in the treatment of venous lake lesions: a prospective clinical study.Lasers in medical science · 2026Article
- Real-time vascular monitoring of PDLs and IPL for vascular treatment: effects of fluence and pulse duration on a rabbit ear model.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Port-wine stain (PWS) is a congenital vascular malformation commonly treated with pulsed dye laser (PDL) therapy. PDL exploits selective photothermolysis, in which hemoglobin in red blood cells (RBCs) absorbs laser energy, generating localized heat that induces endothelial damage. However, in microvessels, axial RBC migration creates a hemoglobin-depleted cell-free layer along the vessel walls, reducing laser efficacy. Hemoglobin vesicles (HbVs)—nano-sized artificial RBCs—distribute uniformly within these layers, offering the potential to enhance hemoglobin distribution and laser absorption. To investigate the impact of HbV administration on PDL therapy, a three-dimensional numerical model of human skin tissue containing vascular networks was developed. Monte Carlo simulations were used to evaluate laser absorption, and thermal conduction analysis was performed to compute temperature distributions and estimate thermal damage via the Arrhenius model. Two conditions were considered: Case 1 (without HbV administration) and Case 2 (with HbV administration). In Case 2, HbV administration increased optical absorption in vessel walls and enhanced thermal damage, particularly in subpapillary vessels. The threshold energy fluence required to induce irreversible thermal damage was reduced, and heat flux at the upper vessel walls was elevated. These findings indicate that HbV administration enhances the homogeneity and efficacy of PDL-induced vascular damage, potentially allowing effective treatment at lower energy fluences while minimizing off-target tissue injury. The study provides a theoretical basis for optimizing PDL parameters in PWS therapy and underscores the potential of patient-specific treatment protocols using artificial blood substitutes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.